期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心力衰竭并心房纤颤患者血浆氨基末端脑利钠肽前体水平的临床观察 被引量：1

原文传递
导出
摘要 目的观察急性心力衰竭患者血浆氨基末端脑利钠肽前体(NT-proBNP)的水平及其与心房纤颤的关系。方法 60例急性心力衰竭患者按房颤、窦性心率分组,采用免疫荧光法测定血浆NT-proBNP水平。结果急性心力衰竭合并房颤组患者血浆NT-proBNP水平明显高于窦性心率组(P<0.05)。结论急性心力衰竭患者的NT-proBNP水平,合并房颤者比窦性心率者高,且与左房内径有明显相关性。
作者 柴晓利
机构地区 湖南省第二人民医院心内科
出处 《实用预防医学》 CAS 2010年第11期2266-2267,共2页 Practical Preventive Medicine
关键词 氨基末端脑利钠肽前体 心力衰竭 心房纤颤 左房内径
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

  • 1NP Consensus Panel 2004 · A clinical approach for the di - agnostic prognostic screening,treatment monitoring, andtherapeutic roles of natriuretic peptides in cardiovasculardiseases [ J ]. Congestive Heart Failure, 2004,10(5) :3.
  • 2夏小杰,昝沁,杨俊芬,黄元涛,曹克将,杜同信,王自正.心房颤动患者血浆心钠素浓度变化的研究[J].放射免疫学杂志,2004,17(1):32-34. 被引量：10
  • 3Khand AU, Rankin AC,Kaye GC, et al. Systematic review of the management of atrial fibrillation in patients with heart failure [ J ]. Ear Heart J,2000,21 (8) :614 - 632.
  • 4Inoue S , Mnra Kami T , Sano K, et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation [ J ]. J Card Fail, 2000,6(2) :92 -96.
  • 5Wzakowska - Kaplonb. Effect of sinus rhythm restoration onplasma brain natriuretic peptide in patients with atrial fibrillation[ J ]. Am J Cardiol, 2004,93:1555 - 1558.
  • 6Ell Inor PT , LOW AF , Patton KK, et al. Discordant atrial natriuretic peptide and brain natriuretic peptide leves in lone atrial fibrillation [ J] . J Am Coll Cardiol , 2005,45:82 -86.
  • 7Maurits A, Jannieb A, Ulrich S. Electrical contractile andstructural re- modeling during atrial fibrillation [ J ]. Cardiovascular Research, 2002, 54:230 - 231.
  • 8高磊,卢才义,李泱,王士雯.充血性心力衰竭合并心房颤动研究进展[J].中华老年多器官疾病杂志,2006,5(1):70-73. 被引量：2

二级参考文献32

  • 1[27]Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure:the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.Am Heart J,2002,144:597-607.
  • 2[28]Echocardiographic predictors of stroke in patients with atrial fibrillation:a prospective study of 1066 patients from 3 clinical trials.Arch Intern Med,1998,158:1316-1320.
  • 3[29]Rogg H,De Gasparo M,Graedel E,et al.Angiotensin Ⅱ-receptor subtypes in human atrialand evidence for alterations in patients with cardiac dysfunction.Eur Heart J,1996,17:1112-1120.
  • 4[30]Swedberg K,Pfeffer M,Cohen-Solal A,et al.Prevention of atrial fibrillation in symptomatic chronic heart failure by candesartan:results from CHARM.J Am Coll Cardiol,2004,43:222A.
  • 5[1]Go AS,Hylek EM,Phillips KA,et al.Prevalence of diagnosed atrial fibrillation in adults:national implications for rhythm management and stroke prevention:the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.JAMA,2001,285:2370-2375.
  • 6[2]Wang TJ,Larson MG,Levy D,et al.Temporal relations of atrial fibrillation and congestive heart failure and their joint infiuence on mortality:the Framingham Study.Circulation,2003,107:2920-2925.
  • 7[3]Middlekauff HR,Stevenson WG,Stevenson LW.Prognostic significance of atrial fibrillation in advanced heart failure:a study of 390 patients.Circulation,1991,84:40-48.
  • 8[4]Nattel S.Ionic determinants of atrial fibrillation and Ca2+channel abnormalities:cause,consequence,or innocent bystander? Circ Res,1999,85:473-476.
  • 9[5]Wijffels MC,Kirchhof C J,Dorland R,et al.Atrial fibrillation begets atrial fibrillation:a study in awake chronically instrumented goats.Circulation,1995,92:1954-1968.
  • 10[6]Li D,Fareh S,Leung TK,et al.Promotion of atrial fibrillation by heart failure in dogs:atrial remodeling of a different sort.Circulation,1999,100:87-95.

共引文献10

同被引文献9

  • 1Levin ER, Gardner DG, Samson WK. Natriuretic peptides. NEngl J Med,1998,339:321-328.
  • 2Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardi-ol, 2007 ,50 : 2357-2368.
  • 3王蔚,杨希兰.基质金属蛋白酶及脑利钠肽对心房颤动患者心房重构的影响.临床研究,2012,9:71-74.
  • 4Morrow DA,Cannon CP,Jesse RL,et al. for the NACB Writ-ing Group. National Academy of Clinical Biochemistry Labo-ratory Medicine practice guidelines : clinical characteristics andutilization of biochemical markers in acute coronary syn-dromes. Circulation, 2007 ,115: e356-e375.
  • 5Ribeiro AL. Natriuretic peptides in elderly people with acutemyocardial infarction. BMJ ,2009,338 : b787.
  • 6Mollmaon H. Weber M, Elsasser A, et al. NT proBNP prediets rhythm stability after cardioversion of lone atrial fibrilla-tion. Circ J,2008,72:921-925.
  • 7Ulimoen SR,Enger S,Tveit A. Impact of atrial fibrillation onNT-proBNP levels in a 75-year-old population. Seand J ClinLab Invest, 2009,69 : 579-584.
  • 8Patton KK, Eninor PT, Heckbert SR, et al. N-terminal pro-BNP-type natriuretic peptide is a major predictor of the devel-opment of atrial fibrillation: the cardiovascular health study.Circulation, 2009 ,120 : 1768-1774.
  • 9袁慧萍.左室射血分数正常的心房颤动患者复律前后脑利钠肽水平变化的研究[J].实用临床医学（江西）,2011,12(10):6-7. 被引量：1

引证文献1

二级引证文献6

实用预防医学
2010年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部